Associations between serum mineral metabolism parameters and mortality in patients on peritoneal dialysis
Authors:
- 22 November 2018
- journal article
- research article
- Published by Wiley in Nephrology
- Vol. 24 (11) , 1148-1156
Abstract
Aim Disturbances in mineral metabolism markers are common in patients with chronic kidney disease but there is no consensus on the association between these markers and clinical outcomes. This study investigated associations between mineral metabolism parameters and mortality in Chinese peritoneal dialysis patients. Methods This was a single centre retrospective cohort study. Incident peritoneal dialysis patients between 1 January 2006 and 31 December 2013 with baseline phosphate, albumin‐corrected calcium, and calcium‐phosphate product data were enrolled. Associations between these parameters and all‐cause and cardiovascular mortality were assessed using multivariable adjusted Cox models. Results Of 1662 patients (mean age: 47.4 ±15.3years), 59.3% were male and 23.8% had diabetes. Over a median 38.1‐month (IQR: 21.3–59.7 months) follow‐up period, 382 (23.0%) patients died. After adjusting for confounders, the higher serum phosphate level (>1.78 mmol/L) and calcium‐phosphate product level (≥4.4 mmol2/L2) were significantly associated with an increased risk for all‐cause mortality (HR:1.818, 95%CI: 1.379‐2.396 and HR:1.735, 95%CI:1.261‐2.386) and cardiovascular mortality (HR:2.069, 95%CI:1.428‐2.998 and HR:2.175, 95%CI:1.450‐3.262), respectively. While each 1 mmol/L higher baseline albumin‐corrected calcium level was associated with an 14.3% (95%CI: 0.749‐0.981) lower risk for all‐cause mortality after adjusting for potential confounders. Conclusion Abnormalities in mineral metabolism markers, particularly higher serum phosphate and calcium‐phosphate product levels, at the commencement of peritoneal dialysis were independently associated with increased all‐cause and cardiovascular mortality in this cohort of peritoneal dialysis patients.Keywords
Funding Information
- National Basic Research Program of China (2016YFC0906101)
- National Natural Science Foundation of China (810731388157061481774069)
- National Natural Science Foundation of China (81774069, 81 570 614, 81 073 138,))
This publication has 18 references indexed in Scilit:
- Hyperphosphatemia Management in Patients with Chronic Kidney DiseaseSaudi Pharmaceutical Journal, 2016
- Calcium, phosphate and calcium phosphate product are markers of outcome in patients with chronic heart failureJournal Of Nephrology, 2014
- Fibroblast growth factor-23 and calcium phosphate product in young chronic kidney disease patients: a cross-sectional studyBMC Nephrology, 2013
- Mineral and bone disorder in Chinese dialysis patients: a multicenter studyBMC Nephrology, 2012
- Bone microarchitecture is more severely affected in patients on hemodialysis than in those receiving peritoneal dialysisKidney International, 2012
- Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES StudyNephrology Dialysis Transplantation, 2010
- Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis populationNephrology Dialysis Transplantation, 2010
- The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: Association With Mortality in Dialysis PatientsAmerican Journal of Kidney Diseases, 2005
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- Interpretation of Serum Calcium in Patients with Abnormal Serum ProteinsBMJ, 1973